Assistant Professor, Clinician-Scientist, Staff Endocrinologist,
Department of Medicine
Division of Endocrinology and Metabolism, University of Ottawa
Ottawa Hospital Research Institute (OHRI), The Ottawa Hospital
Ottawa, Ontario, Canada
Since April 2025, I have served as Assistant Professor in the Division of Endocrinology and Metabolism at the University of Ottawa, Clinician‑Scientist at the Ottawa Hospital Research Institute, and Staff Endocrinologist at The Ottawa Hospital—an integrated platform now devoted to Cushing’s syndrome and other cortisol disorders. Building on complementary mentorships with Susan Webb and Elena Valassi (Barcelona), Shereen Ezzat (University of Toronto), and André Lacroix (CHUM), I bring a bench‑to‑technology‑to‑bedside perspective and a national network to a field with profound unmet needs driven by under‑recognition, diagnostic complexity, and delays that worsen outcomes. My central goal is to shorten time‑to‑diagnosis and identify high‑risk populations for Cushing’s disease and related cortisol‑producing tumors, pairing advanced clinical phenotyping with multidisciplinary digital approaches. Since arriving in Ottawa, I have established a multidisciplinary pituitary tumor board for the most challenging cases; implemented a desmopressin (DDAVP) plus dexamethasone protocol to distinguish Cushing’s from pseudo‑Cushing’s; initiated a national registry; and designed technology‑enabled diagnostics and care pathways to speed detection, improve inpatient management of severe hypercortisolism, and empower patients. I am developing innovative tools for cortisol measurement and digital solutions that support care across the continuum (screening, diagnosis, treatment, survivorship). My capacity to coordinate across centers is evidenced by first‑author leadership of the Canadian long‑term extension of osilodrostat therapy in Cushing’s disease (presented at ENDO 2024; manuscript in submission) with teams in Halifax, CHUM Montreal, Alberta, and Sherbrooke. In 2025, I was invited as a national Cushing’s expert to speak at CSEM’s Rare Disease Rounds and CSEM Cushing’s Webinar scheduled for November 2025, reflecting national recognition and reach. Fluent in Spanish, Catalan, English, French, and Korean, I align diverse teams and move projects from concept to implementation, positioning me to succeed as PI with rigor, speed, and measurable patient benefit.
Disclosure(s): Recordati Rare Disease: Board Member (Terminated, November 8, 2025), Grant/Research Support (Terminated, November 8, 2025)
Thursday, November 27, 2025
13:00 - 14:15 Toronto